Showing all 7 results
Alfacalcidol Softgel Capsules
FreeProduct Composition & Strength
We supply this product as a Liquid-Filled Soft Gelatin Capsule, packed in highly protective, opaque blister strips to prevent the extreme light-degradation associated with vitamin D analogues.
Active Ingredient Strength Primary Clinical Use Alfacalcidol BP/EP 0.25 mcg (Micrograms) Initial Titration / Pediatric / Maintenance Dosing Alfacalcidol BP/EP 0.5 mcg (Micrograms) Standard Adult Dialysis / Osteoporosis Dosing Alfacalcidol BP/EP 1.0 mcg (Micrograms) Severe Hypocalcemia / High-PTH Suppression Excipients Refined Arachis (Peanut) Oil / BHA Lipid Carrier System / Antioxidant Stabilizer *Pack Sizes: 10×10 Opaque Alu-PVC Blisters or Alu-Alu Blisters. (Opaque packaging is an absolute necessity to maintain microgram API stability).
Cefoperazone & Tazobactam Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Dry Powder for Injection in glass vials. The standard ratio is 8:1.
Strength Variant Cefoperazone Content Tazobactam Content Ratio 1.125 g Vial 1000 mg (1 g) 125 mg (Sodium) 8:1 (Standard) Excipients None (Sterile Blend) – – *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials with Water for Injection (WFI).
1.125 g Vial 1000 mg (1 g) 125 mg (Sodium) 8:1 (Standard) Excipients None (Sterile Blend) – – Losartan Tablet
FreeProduct Composition & Available Strengths
We supply Losartan Potassium across the complete, internationally recognized therapeutic range to facilitate progressive dose titrations and precise maintenance regimens.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Losartan Potassium USP / BP / IP 25 mg Oral Solid Film-Coated Tablet Pediatric & Low-Dose Titration: For introductory pediatric hypertension care or initial combination-therapy building. Losartan Potassium USP / BP / IP 50 mg Oral Solid Film-Coated Tablet Core Commercial Volume: Standard international baseline daily dose for mild-to-moderate chronic essential hypertension. Losartan Potassium USP / BP / IP 100 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: For advanced hypertensive management, diabetic nephropathy progression delay, and stroke risk reduction in left ventricular hypertrophy. Spironolactone Tablets
FreeSpironolactone Tablets IP 25 mg
Each Filmcoated tablet contains :
Spironolactone IP 25 mgSpironolactone Tablets IP
Each Film Coated Contanis:
Spironolactone IP 50 mgUsage: – high blood pressure and heart failure
Category: – Diuretic Drugs
Therapeutic category: – Diuretic
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Tacrolimus Tablets
FreeTacrolimus Tablets 1 MG film coated tablet: Anhydrous Tacrolimus 1 MG
Usage: – to prevent rejection of a kidney, heart, or liver transplant
Category: – Generic drugs & Medicine
Therapeutic category: – Generic
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Tolvaptan Tablets
FreeTolvaptan tablets primarily contain Tolvaptan as the active pharmaceutical ingredient. It is a selective vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) and to slow kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD)
Torsemide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips, providing dosage flexibility for both mild hypertension and severe renal failure.
Active Ingredient Strength Primary Clinical Use Torsemide USP/Ph.Eur. 5 mg / 10 mg Standard maintenance therapy for mild-to-moderate congestive heart failure and essential hypertension. Torsemide USP/Ph.Eur. 20 mg Acute diuresis for severe hepatic cirrhosis and advanced heart failure exacerbations. Torsemide USP/Ph.Eur. 100 mg High-dose therapy specifically reserved for patients with severe chronic renal failure (CRF) and massive fluid overload. Excipients Lactose Monohydrate / Crospovidone / Magnesium Stearate Diluent / Superdisintegrant / Lubricant (Engineered for immediate, predictable gastric dissolution)
